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THE DEPENDENCE OF THE PARAMETERS OF DAILY 
BLOOD PRESSURE MONITORING ON BODY MASS INDEX IN 
PATIENTS WITH ARTERIAL HYPERTENSION. 
 
In the XXI century, the problem of overweight and obesity affects 
the formation of cardiovascular risk becomes increasingly relevant. 
Arterial hypertension (AH) combined with common risk factors such 
as dyslipidemia, obesity, hypodynamia, smoking, diabetes mellitus 
(DM) causes at least 70–75% of stroke, 80–90% of myocardial 
infarctions, leading to premature disability and mortality of patients.  
The aim of the study was to study the relationship between the daily 
profile of blood pressure with BMI in patients with hypertension in 
stage 2.  
Materials and methods. 120 persons with AH stage II were 
screened and divided into 2 groups according to body mass index 
(BMI). 60 patients with BMI 18–25 kg/m2 belonged to the Ist group 
and 60 patients with BMI ≥ 25 kg/m2 belonged to the IInd group. All 
patients had general-clinical, anthropometric studies with 
measurements of height, body weight, body mass index (BMI), daily 
blood pressure monitoring. 
 Results and discussion. According to the daily profile of blood 
pressure, among the patients of both groups revealed: "dippers" – 43 
(35.8%), non-dippers – 71 (59.2%), "over-dippers" – 2 men (1.7 %), 
"night-payers" – 4 people (3.3%). In the group with BMI 18–
25 kg/m
2
, 53.3% of the patients had a physiological rhythm, 43.3% of 
patients had the phenomenon of "non-dippers". At the same time, 
among 80% of patients in the BMI group ≥ 25 kg/m2 had an adverse 
profile of non-dippers (73.3%) and 6.7% had night-hypertension 
“night-peakers”. Determination of the time index of hypertension 
showed that, the average daily level of systolic blood pressure (SBP) 
in group II is 1.3 times as much as in group I (p <0.05). It is 
important that the increase in the daily level of diastolic blood 
pressure (DBP) in group II was 1.6 times higher than that of group I, 
and also significantly exceeded the level of SBP in group II 
(p <0.05). And it was also found that patients in group II had 
significantly increased the speed of morning rise of SBP and DBP in 
comparison with the Ist group of patients (p <0,05). Conclusions. In 
patients with hypertension in stage 2 and BMI > 25 kg/m
2
, 73.3% of 
non-dippers were found, and 6.7% of those with night-hypertension 
were night-peakers. This significantly exceeds the rates of patients 
with hypertension in stage 2 without excess weight. Patients with 
stage 2 of hypertension and obesity had significantly higher values of 
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systolic and diastolic blood pressure, the time index of blood 
pressure, and the onset of elevated blood pressure compared with 
those with BMI < 25 kg/m
2
. 
Keywords: hypertension, obesity, daily blood pressure profile, 
time index of blood pressure, morning rise of blood pressure. 
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ЗАЛЕЖНІСТЬ ПОКАЗНИКІВ ДОБОВОГО МОНІТОРИНГУ 
АРТЕРІАЛЬНОГО ТИСКУ ВІД ІНДЕКСУ МАСИ ТІЛА 
У ХВОРИХ НА АРТЕРІАЛЬНУ ГІПЕРТЕНЗІЮ 2 СТАДІЇ.  
  
У XXI столітті все більш актуальною стає проблема впливу 
надмірної ваги та ожиріння на формування серцево-судинного ри-
зику. Артеріальна гіпертензія (АГ) в поєднанні з поширеними чин-
никами ризику, таких як дисліпідемія, ожиріння, гіподинамія, па-
ління, цукровий діабет (ЦД), стає причиною не менше ніж 70–75% 
інсультів, 80–90% інфарктів міокарда , що призводять до передчас-
ної інвалідизації та смертності пацієнтів. Метою дослідження було 
вивчення взаємозв’язку показників добового профілю артеріально-
го тиску (АТ) з індексом маси тіла (ІМТ) у хворих на АГ ІІ стадії. 
Матеріали і методи. Обстежено 120 осіб з АГ ІІ стадії, які були по-
ділені на 2 групи за індексом маси тіла (ІМТ): І групу склали паціє-
нти із ІМТ 18–25 кг/м2, ІІ групу – пацієнти з ІМТ ≥ 25 кг/м2. Усім 
пацієнтам проводили загальноклінічні, антропометричні дослі-
дження з вимірюванням росту, маси тіла, обчисленням ІМТ, добове 
моніторування АТ.  
Результати та їх обговорення. За добовим профілем АТ серед 
пацієнтів обох груп виявлено: «dippers» – 43 чоловік (35,8%) , «non-
dippers» – 71 чоловік (59,2%), «over-dippers» – 2 чоловіка (1,7%), 
«night-pеаkers» – 4 чоловік (3,3%). У групі з ІМТ 18–25 кг/м2 53,3 % 
хворих мали збережений фізіологічний ритм, 43,3 % хворих мали 
феномен «non-dippers», в той же час як серед 80 % пацієнтів групи 
ІМТ ≥ 25 кг/м2 мали несприятливий профіль АТ – «non-dippers» 
(73,3%) та у 6,7% - реєструвалась нічна гіпертензія «night-pеаkers». 
Визначення індексу часу (ІЧ) гіпертензії показало, що у пацієнтів 
ІІ групи середній добовий рівень систолічного артеріального тиску 
(САТ) у 1,3 рази більше порівняно з I групою (р<0,05). Звертає ува-
гу, що підвищення добового рівня ДАТ у II групі в 1,6 рази пере-
вищувало значення в I групі (р < 0,05). Також виявлено, що хворі 
II групи мали достовірно збільшену швидкість ранкового підйому 
САТ та ДАТ порівняно з І групою хворих (р < 0,05). Висновки. У 
пацієнтів з АГ II стадії та ІМТ > 25 кг/м2 виявлено 73,3% чоловік 
«non-dippers», та 6,7 % чоловік з нічною гіпертензією – «night-
peakers», що значно перевищує показники хворих на АГ ІІ стадії без 
надлишкової маси . Хворі на АГ II стадії та ожирінням мали досто-
вірно вищі значення систолічного та діастолічного АТ, індексу часу 
АТ, вранішнього підйому АТ порівняно з хворими ІМТ < 25 кг/м2. 
Ключові слова: артеріальна гіпертензія, ожиріння, добовий 
профіль артеріального тиску, індекс часу АТ, вранішній підйом АТ.  
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Introduction 
Arterial hypertension (AH) is the most common 
cardiovascular disease (CVD) and belongs to 
"diseases of a civilization". CVD causes 
approximately 17 million deaths per year, nearly a 
third of the world's total deaths [1]. As of 01.01.2014, 
12 153 040 patients with hypertension are registered in 
Ukraine, which is about a third of the adult population 
[2].When combined with common risk factors such as 
dyslipidemia, obesity, physical inactivity, smoking, 
diabetes mellitus (DM), AH is the cause of at least 70–
75% of strokes, 80–90% of myocardial infarctions, 
which is the main risk factor for many cardiovascular 
complications that lead to premature disability and 
mortality of patients. AH significantly increases the 
risk of kidney damage, stroke, heart failure (HF), 
peripheral vascular disease and cardiovascular death 
[3; 4]. 
In the XXI century, the problem of excessive 
weight and obesity, as well as their impact on the 
formation of cardiovascular risk becomes more urgent. 
Obesity was recognized by the World Health 
Organization (WHO) as a new noninfectious 
"epidemic" of our time [3; 6]. According to WHO 
data, more than 30% of the world's population has 
excessive body weight (EBW), among them 16.8% 
are women and 14% are men. In Ukraine in 2011, 
30% of the adult population and 10% of children had 
EBW (among them 50.5% were men, 56% were 
women), of which about 20% were obese. In 2014, 
39% of people aged 18 and over had EBW and 13% 
were obese [3; 8]. European guidelines for CVD 
prevention, 2012, indicate that EBW and obesity are 
associated with the risk of death from CVD. There is a 
direct positive relationship between body mass index 
(BMI) and all-cause mortality, the lowest all-cause 
mortality rate is observed at a BMI of 20–25 kg/m2, 
and further weight loss has no positive effect on the 
risk of CVD [9]. It was found that the incidence of AH 
in obesity is 75%, type 2 diabetes mellitus (DM) – 
57%, coronary heart disease (CHD) – 20% [7]. The 
combination of AH, obesity and dyslipidemia causes 
early development of atherosclerosis and 
atherothrombosis, which increases overall and 
cardiovascular morbidity and mortality [10]. 
There is a direct relationship between body weight 
and BP: EBW is associated with a 2–6-fold increase in 
the AH risk [11;15]. It is known that increase of BP by 
20/10 mm Hg increases the risk of cardiovascular 
events twofold, and epidemiological studies have 
shown a relationship between BMI and BP [12]. 
According to the Framingham study, AH in 80% of 
men and 61% of women is associated with EBW. 
More than 85% of patients with AH have BMI  ≥ 
25 kg/m
2
. An increase of body weight by 4.5 kg is 
accompanied by elevated systolic blood pressure 
(SBP) in men by 4.4 mm Hg, in women by 4.2 mm 
Hg [13]. In people, suffering from obesity, the risk of 
AH increases by 5 times compared to slim people, and 
in 2/3 of patients, increased BP is a direct consequence 
of excessive weight [14;15]. At the same time, a high 
initial BMI serves as an increase in the "normal" BP 
range and is associated with high AH risk. Thus, a 
third of people with normal BP and obesity developed 
AH after an average of 14.5 years [14]. A 7 year 
study, which included more than 300 000 adults, 
showed that an increase in BMI by 1 was associated 
with a 9% difference in the CHD incidence [16].  
BP is a physiological integrating indicator with a 
distinct circadian rhythm. Elevated blood pressure is 
an important, but not the only factor, determining the 
prognosis of cardiovascular complications. 
Informative indicators are the BP variability, 
especially circadian rhythm, daily index, time index 
and rate of morning BP increase. These characteristics 
are established during the daily blood pressure 
monitoring (DBPM) [17]. DBPM has several 
advantages over office measurement (WHO/MTAG, 
1999): DBPM data more accurately reflects BP in the 
normal life conditions of the patients; average BP 
values, obtained with DBPM, are more closely 
associated with lesions of target organs than clinical 
measurement data; DBPM data before treatment may 
have prognostic value in the development of 
cardiovascular complications; regression of the lesion 
of target organ is closely associated with changes in 
the average daily BP values than with the level of 
clinical BP. DBPM is the most informative method in 
the study of chronobiological changes in indicators, 
the assessment of which is necessary for the accurate 
interpretation of various clinical manifestations of the 
disease and determination of the effectiveness of 
prescribed treatment [17].  
The objective of this study was to determine the 
dependence of the daily BP profile from BMI in 
patients with stage II AH. 
Materials and methods. 
The study involved 120 people with stage II AH 
aged from 26 to 75 years (average age is 51 years), of 
which 38.3% were men and 61.7% were women. 
Depending on BMI all patients were divided into 2 
groups: Group I consisted of 60 people with a BMI of 
23.1 ± 1.80 kg/m2, group II consisted of 60 people 
with a BMI ≥ 31.5 ± 3.96 kg/m2 (p < 0.05).  
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In total, there were 1.6 times more women, 45% 
were patients from 51 to 59 years old. Gender equality 
was observed in this age group. In the group of 
patients with BMI 18–25 kg/m2, there were 60% men 
and 40% women, and in the group with BMI ≥ 
25 kg/m
2
 there were 2 times more women (68.3%). 
The gender structure of patients, obtained by us, 
coincides with epidemiological studies on EBW and 
obesity in Ukraine [3; 8]. 
Verification of the diagnosis, determination of the 
stage and degree of AH was conducted in accordance 
with the criteria of unified clinical protocol of primary, 
secondary (specialized) and tertiary (highly 
specialized) medical care No. 564 of the MOH of 
Ukraine (dated 13.06.2016) [2]. 
The exclusion criteria were patients with 
symptomatic AH, myocardial infarction or unstable 
angina, effort angina of the II–IV functional class, 
obesity in endocrinological diseases, diabetes mellitus, 
acute infectious diseases, exacerbation of chronic 
infectious diseases, neoplasms, mental disorders and 
diseases of the nervous system, systemic connective 
tissue diseases, acute cerebrovascular accidents, 
refusal to participate in the study. 
All patients underwent general clinical, 
anthropometric examinations with measurement of 
height, body weight, calculation of BMI according to 
the Quetelet formula. The criteria for the distribution 
of patients according to BMI were in line with WHO 
recommendations (2009): BMI from 18.5 to 
24.9 kg/m
2
 was regarded as normal body weight, BMI 
from 25.0 to 29.9 kg/m
2
 – as an excessive weight, 
BMI greater than 30.0 kg/m
2
 – as obesity (I degree 
obesity – 30.0–34.9 kg/m2, II degree – 35.0–
39.9 kg/m
2
, III degree obesity – more than 40 kg/m2) 
[20]. DBPM was performed using the MAVRM 04 
apparatus (MeditechLtd., Hungary), according to the 
standard protocol. BP was measured every 15 minutes 
during the day from 7 to 23 o'clock and every 30 
minutes during the night, from 23 to 7 o'clock [17; 
18]. The obtained data were subjected to computer 
analysis using a special program. Average values of 
daily systolic (SBP) and diastolic (DBP) BP; time 
index (TI) for SBP and DBP for active and passive 
periods (% of time during which the PB values exceed 
the critical level – 140/90 mm Hg for the daytime and 
120/80 mm Hg for the nighttime BP); daily index (DI) 
were determined. The morning increase value (MIV) 
of SBP and DBP (from 5 to 10 o'clock) was calculated 
by the formula: BPMIV = BPmax – BPmin during 
this time interval [18]. BP DI was characterized as 
follows : patients with a 10–20% decrease in SBP 
during the nighttime were classified as "dippers", with 
a 10% decrease as "non-dippers", with a > 20% 
decrease as "over-dipper". In the presence of nocturnal 
hypertension (BP > 125/75 mm Hg) patients were 
referred to as "night-peakers" [17; 19]. Most 
researchers believe that investigation and changes in 
blood pressure at nighttime are more important and 
informative than BP in the daytime, for the prediction 
of fatal events and cardiovascular complications, 
namely left ventricular hypertrophy, 
microalbuminuria. And the presence of a persistent BP 
increase leads to the involvement of target organs in 
the pathological process [20]. 
The Statistica for Windows 6.0 software package 
was used for statistical data processing. At the first 
stage of calculation, descriptive statistics for the 
indicators, measured on a quantitative scale, were 
obtained. The probability of differences for 
comparison of mean values was determined using 
Student's t-test (p). The values of the studied 
parameters are given in the form of M ± m, where M 
is the arithmetic mean, m is the standard error. The 
differences were considered statistically significant at 
p < 0.05. 
Study results and discussion 
According to the daily BP profile in patients of 
both groups were revealed: "dippers" – 43 patients 
(35.8%), "non-dippers" – 71 patient (59.2%), "over-
dippers" – 2 patients (1.7%), "night-peakers" – 4 
patients (3.3%). Obtained data indicates that only one 
third (35.8%) of patients with AH retain the most 
favorable type of daily BP profile – "dippers".  
Among group I patients (with BMI < 25 kg/m
2
) 
the preserved physiological rhythm of "dippers" was 
revealed, 43.3% showed "non-dippers" profile, and 
3.3% showed an excessive BP decrease at nighttime – 
"over-dippers", there were no patients with nocturnal 
hypertension. Among group II patients (with BMI > 
25 kg/m
2
) there were only 20% of patients with daily 
"dipper" rhythm, and there were 1.7 times more "non-
dippers" (73.3%) compared to group I (p < 0.05). 
Nocturnal hypertension – "night-peakers" was 
observed in 6.7% of group II patients (Figure 1). Thus, 
in group I, with BMI within the normal range, more 
than half of the patients had a preserved physiological 
rhythm, and the vast majority (80 %) of group II 
patients (BMI > 25 kg/m
2
) had an unfavorable BP 
profile – "non-dippers" (73.3%) and 6.7% showed 
nocturnal hypertension (p < 0.05). 
Further analysis of the DBPM parameters related 
to SBP/DBP TI and the morning increase value of BP 
(MIV SBP/DBP). The results of these studies are 
shown in Table 1. 
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Table 1 – Indicators of daily monitoring in patients with stage II AH (M ± m) 
Indicator Group I (n= 60) Group II (n= 60) р 
HR, bpm 76.2 ± 1.41 75.4 ± 2.49 p >0.05 
BP  SBP mm Hg 138.2 ± 3.24 147.6 ± 4.25 р <0.05 
DBP mm Hg 88.4 ± 2.63 103.8 ± 3.64 р <0.05 
Time index SBP day, % 53.4 ± 1.12 61.8 ± 1.28 р <0.05 
DBP day, % 49.9 ± 1.62 57.06 ± 1.40 р <0.05 
Morning increase value, 
mm Hg 
SBP mm Hg/h 54.4 ± 2.32 60.48 ± 1.26 р <0.05 
DBP mm Hg/h 41.4 ± 2.23 46.2 ± 0.87 р <0.05 
Note: – р<0.05 compared to group I patients with stage II AH with EBW 
The result of determination of hypertension TI 
showed that in group II patients the average daily 
SBP and DBP level is significantly higher 
compared to group I patients (p < 0.05). It is 
noteworthy that the increase in the daily SBP level 
in group II was 1.2 times higher than in group I, 
namely, hypertension TI in group I was 53.4 ± 1.12, 
and in group II – 61.8 ± 1.28 (p < 0.05). 
Hypertension TI characterizes hyperbaric loads of 
target organs more accurately than average BP 
values and can be used to predict the personal risk 
of cardiovascular events in patients with stage II 
AH [20]. 
 
    % 
 
Figure 1 – Types of daily BP profile depending on BMI 
It was also revealed that group II patients had 
significantly higher rate of morning SBP and DBP 
increase in comparison with group I patients (p < 
0.05). The rate of morning SBP increase in group I 
is (54.4  ± 2.32) mm Hg vs (60.48   ±  1.26) mm Hg 
in group II and DBP is (41.4  ±  2.23) mm Hg vs 
(46.2 ± 0.87) mm Hg, respectively. It is known that 
the morning period is considered to be the time of 
"cardiovascular disasters”, which is associated with 
the physiological activation of sympathoadrenal 
and renin-angiotensin-aldosterone systems and 
leads to increased vascular tone, decreased 
fibrinolytic properties of blood and activation of 
platelet aggregation properties, which leads to the 
development of myocardial infarction, sudden 
death, stroke in the morning, so increase of BP rate 
in the period from 4 to 10 am is considered as a 
starting mechanism for the development of 
complications [20]. 
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Conclusions  
1. In patients with stage II AH and obesity, 
80% of patients with an unfavorable daily profile in 
terms of cardiovascular complications were 
identified, namely: 73.3% of patients with 
insufficient BP reduction at nighttime – "non-
dippers", and 6.7% of men with night hypertension 
– "night-peakers", which significantly exceeds 
these figures among patients with AH with normal 
body weight. 
2. Patients with stage II AH and BMI > 
25 kg/m
2
 had significantly higher values of systolic 
and diastolic BP, BP time index, morning BP 
increase compared to patients with normal body 
weight. 
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